Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
4,214,831
-
Share change
-
+638,119
-
Total reported value
-
$204,391,820
-
Put/Call ratio
-
28%
-
Price per share
-
$48.56
-
Number of holders
-
81
-
Value change
-
+$32,481,115
-
Number of buys
-
43
-
Number of sells
-
25
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2018
As of 30 Sep 2018 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,214,831 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, GOLDMAN SACHS GROUP INC, DEUTSCHE BANK AG\, HighTower Advisors, LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BNP PARIBAS ARBITRAGE, SA, Baird Financial Group, Inc., LAZARD ASSET MANAGEMENT LLC, and UBS Group AG.
This table shows 81 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.